Central Institute for Experimental Animals, Kawasaki, Kanagawa, Japan.
J Cell Physiol. 2018 May;233(5):3723-3728. doi: 10.1002/jcp.26045. Epub 2017 Jul 4.
Humanized mice are superior to rodents for preclinical evaluation of the efficacy and safety of drug candidates using human cells or tissues. During the past decade, humanized mouse technology has been greatly advanced by the establishment of novel platforms of genetically modified immunodeficient mice. Several human diseases can be recapitulated using humanized mice due to the improved engraftment and differentiation capacity of human cells or tissues. In this review, we discuss current advanced humanized mouse models that recapitulate human diseases including cancer, allergy, and graft-versus-host disease.
人源化小鼠在使用人源细胞或组织对候选药物的疗效和安全性进行临床前评估方面优于啮齿动物。在过去十年中,通过建立新型基因修饰免疫缺陷小鼠平台,人源化小鼠技术得到了极大的发展。由于人源细胞或组织的植入和分化能力得到了提高,几种人类疾病可以用人源化小鼠来重现。在这篇综述中,我们讨论了目前能够重现人类疾病(包括癌症、过敏和移植物抗宿主病)的先进的人源化小鼠模型。